홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Sodium hydride → (S)-Ethyl 2-(7-(4-(allyloxy)-4-methylpiperidin-1-yl)-2-(3-(2-bromophenyl)prop-1-en-1-yl)-5-methylpyrazolo[1,5-a]pyrimidin-6-yl)-2-(tert-butoxy)acetate

HRID 921103
노트
인쇄 미리보기

반응식

HRID 921103 반응식
[I-].[Br:2][C:3]1[CH:29]=[CH:28][CH:27]=[CH:26][C:4]=1[CH2:5][CH2:6][P+](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1.[H-].[Na+].[CH2:32]([O:35][C:36]1([CH3:65])[CH2:41][CH2:40][N:39]([C:42]2[N:47]3[N:48]=[C:49]([CH:51]=O)[CH:50]=[C:46]3[N:45]=[C:44]([CH3:53])[C:43]=2[C@H:54]([O:60][C:61]([CH3:64])([CH3:63])[CH3:62])[C:55]([O:57][CH2:58][CH3:59])=[O:56])[CH2:38][CH2:37]1)[CH:33]=[CH2:34]>C1COCC1>[CH2:32]([O:35][C:36]1([CH3:65])[CH2:37][CH2:38][N:39]([C:42]2[N:47]3[N:48]=[C:49]([CH:51]=[CH:6][CH2:5][C:4]4[CH:26]=[CH:27][CH:28]=[CH:29][C:3]=4[Br:2])[CH:50]=[C:46]3[N:45]=[C:44]([CH3:53])[C:43]=2[C@H:54]([O:60][C:61]([CH3:64])([CH3:63])[CH3:62])[C:55]([O:57][CH2:58][CH3:59])=[O:56])[CH2:40][CH2:41]1)[CH:33]=[CH2:34]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 24758Sodium hydrideHCID 118307054(2-Bromophenethyl)triphenylphosphonium iodideHCID 118318786(S)-Ethyl 2-(7-(4-(allyloxy)-4-methylpiperidin-1-yl)-2-formyl-5-methylpyrazolo[1,5-a]pyrimidin-6-yl)-2-(tert-butoxy)acetate

생성물 1

HCID 123595847(S)-Ethyl 2-(7-(4-(allyloxy)-4-methylpiperidin-1-yl)-2-(3-(2-bromophenyl)prop-1-en-1-yl)-5-methylpyrazolo[1,5-a]pyrimidin-6-yl)-2-(tert-butoxy)acetate수율 57%

시약·촉매·용매 1

HCID 8028Tetrahydrofuran용매2회

실험 절차

To a suspension of (2-bromophenethyl)triphenylphosphonium iodide (0.121 g, 0.212 mmol) in THF (1 ml) at 0° C. was added sodium hydride (8.68 mg, 0.217 mmol) and the resulting mixture was stirred at rt for 45 min. The mixture was cooled to −78° C. and (S)-ethyl 2-(7-(4-(allyloxy)-4-methylpiperidin-1-yl)-2-formyl-5-methylpyrazolo[1,5-a]pyrimidin-6-yl)-2-(tert-butoxy)acetate (0.050 g, 0.106 mmol) dissolved in THF (1 ml) was added dropwise and the mixture was stirred at −78° C. for 1 h then warmed to room temperature and stirred 2 h. The reaction was quenched with water and the product was extracted with EtOAc. The organic phase was washed with brine, dried (Na2SO4), filtered and concentrated. The residue was purified by flash chromatography (Biotage; 0%-50% EtOAc/hexane; 20 CV) to give the title compound (0.0386 g, 0.060 mmol, 57.0% yield) as a pale yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.65-7.50 (m, 1H), 7.40-7.30 (m, 1H), 7.28-7.20 (m, 1H), 7.17-7.05 (m, 1H), 6.73-6.55 (m, 1H), 6.54-6.44 (m, 1H), 6.11-5.74 (m, 3H), 5.56-4.97 (m, 2H), 4.33-4.11 (m, 4H), 4.07-3.98 (m, 1H), 3.94 (d, J=4.4 Hz, 1H), 2.62 (s, 3H), 2.01-1.79 (m, 3H), 1.77-1.64 (m, 1H), 1.29-1.19 (m, 15H), (4 piperidine protons not visible in NMR). LCMS (M+H) calcd for C33H43BrN4O4: 640.24. found: 641.4.

후처리

  1. temperatureThe mixture was cooled to −78° C.
  2. additionwas added dropwise
  3. stirringthe mixture was stirred at −78° C. for 1 h
  4. temperaturethen warmed to room temperature
  5. stirringstirred 2 h
  6. customThe reaction was quenched with water
  7. extractionthe product was extracted with EtOAc
  8. washThe organic phase was washed with brine
  9. dry with materialdried (Na2SO4)
  10. filtrationfiltered
  11. concentrationconcentrated
  12. customThe residue was purified by flash chromatography (Biotage; 0%-50% EtOAc/hexane; 20 CV)

출처 및 근거

ORD 기록
ord-a5a7b94b91734dec940df607425d03b7
출처 데이터셋
uspto-grants-2016_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09273067B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트